ONEM - ONEM STOCK NEWS

On September 9, 2021, 1Life Healthcare, Inc. (One Medical) announced that its CEO Amir Dan Rubin and CFO Bjorn Thaler will participate in two upcoming investor conferences. The first is the Morgan Stanley Virtual Global Healthcare Conference on September 14 at 11:45 a.m. PT, featuring a fireside chat. The second is Baird’s 2021 Global Healthcare Conference on September 15 at 8:25 a.m. PT. One Medical aims to transform healthcare through its technology-driven model, offering accessible digital and in-office services.

One Medical (Nasdaq: ONEM) has completed the acquisition of Iora Health, enhancing its capacity to serve Medicare populations. The deal, involving approximately 56 million shares, signifies a strategic expansion into new geographies, potentially reaching 40% of the U.S. population with an addressable market of $870 billion. With Iora's 39,000 patients now included, One Medical anticipates improved health outcomes and reduced care costs. Financial guidance for Q3 2021 includes projected revenue of $140-$148 million, with 691,000 total members expected by September 30, 2021.

One Medical (NASDAQ: ONEM) announced the appointment of Mary Ann Tocio to its board of directors. Tocio, former President and COO of Bright Horizons Family Solutions, brings over 30 years of leadership and operational experience, particularly in healthcare management. She has served on several boards, enhancing her suitability for the role. The CEO, Amir Dan Rubin, expressed excitement over her joining during a pivotal time for the organization, emphasizing Tocio’s healthcare expertise and insights.

One Medical (NASDAQ: ONEM) has been recognized as the top provider of HIV care in New York City, achieving 100% viral load suppression among its HIV patients, according to a recent report by the NYC Health Department. The analysis ranked 62 facilities based on their effectiveness in managing HIV care. One Medical's model demonstrated superior patient outcomes with zero co-infections of Hepatitis C. Their multi-modal approach includes technology-driven communication and 24/7 virtual support, enhancing chronic disease management and patient adherence.

A new study by One Medical (NASDAQ: ONEM) and Workplace Intelligence reveals that healthcare benefits hold paramount importance for employees post-pandemic. Conducted among over 1,600 U.S. employees and HR leaders, the study indicates that 54% of employees have postponed healthcare, leading to adverse health consequences. Remarkably, 65% would forgo perks like bonuses for enhanced healthcare benefits. Additionally, 86% of HR leaders anticipate rising healthcare costs, predicting an average 7.5% increase in 2022. Companies that prioritize healthcare are likely to retain talent in a competitive market.

One Medical (Nasdaq: ONEM) reported a strong performance for Q2 2021, with membership reaching 621,000, marking a 31% year-over-year increase. Net revenue surged 54% to $120.4 million compared to the previous year. Despite these gains, the company reported a net loss of $41.3 million, equivalent to 34% of net revenue. Cash and short-term marketable securities stood at $653.8 million. The company announced plans to acquire Iora Health to enhance its position in value-based healthcare. Guidance for Q3 and full year 2021 was also updated.

1Life Healthcare, Inc. (One Medical) will release its second quarter 2021 results on August 4, 2021, after market close. A conference call will follow at 1:30 p.m. PT to discuss these financial results. Participants can access the call via dial-in or through a live audio webcast available at https://investor.onemedical.com. A replay will be available shortly after the call and will remain accessible for about 90 days. One Medical aims to enhance healthcare through a technology-driven, membership-based model that prioritizes member satisfaction.

One Medical (NASDAQ: ONEM) has appointed Scott C. Taylor to its board of directors. Taylor is a seasoned executive with extensive experience in corporate governance and legal affairs, having previously served as General Counsel at Symantec Corporation. CEO Amir Dan Rubin expressed enthusiasm for Taylor's leadership and experience, noting his valuable insights for One Medical's mission to transform healthcare. Taylor holds a juris doctorate from George Washington University and a bachelor's in International Relations from Stanford University.

One Medical (ONEM) has announced a definitive agreement to acquire Iora Health in an all-stock transaction valued at approximately $2.1 billion. This merger aims to expand One Medical's service capabilities to Medicare populations, estimated to increase the market opportunity to $870 billion. Following the acquisition, Iora shareholders will own about 26.75% of the combined entity. The deal is expected to close in late Q3 or Q4 of 2021, subject to customary approvals. Significant annual synergies of $350+ million are anticipated by 2025.